Patents by Inventor Steven Stone

Steven Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Procedure guidance and training apparatus, methods and systems
    Patent number: 12106678
    Abstract: Procedure training apparatus, methods and systems which in one embodiment allow surgical trainees to receive expert clinical guidance during live surgery or to practice surgical skills on anatomical models in a realistic manner with an augmented reality headset which is in audio and visual communication with a remotely located trainer having a similar AR headset. A unique feature of the system includes providing live or static imaging of the surgical site to the AR headsets of the trainee and trainer wherein the imaging is provided from medical or other devices (e.g., ultrasound) through a device(s) media hub. The images are displayed in the field of view of the surgeon so that they may see their hands, the patient (or model) and the imaging simultaneously. Controls allow the imaging on the respective AR headsets to be switched on command typically by the trainer which allows the trainer to deliver the trainer's surgical site image (e.g.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: October 1, 2024
    Assignee: Simulated Inanimate Models, LLC
    Inventors: Nelson Stone, Steven Griffith, Jonathan Stone
  • CANCER BIOMARKERS
    Publication number: 20240182979
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: February 14, 2024
    Publication date: June 6, 2024
    Applicant: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • SYSTEMS AND METHODS FOR CLASSIFYING THE STATUS OF A TRANSPLANT
    Publication number: 20230352144
    Abstract: Disclosed herein are systems, kits, and methods for classifying the status of a transplant based on expression levels of a plurality of genes from a biological sample of a transplant recipient. The status of a transplant may be classified based on a predictive rejection classification including, but not limited to, antibody-mediated rejection (ABMR), T-cell mediated rejection (TCMR), mixed ABMR+TCMR, and no rejection. The predictive rejection classification may be assigned based on probability rejection scores, and a probability rejection score may be assigned to each rejection label. In some embodiments, the rejection label having the highest probability rejection score amongst the plurality of rejection labels may be assigned as the predictive rejection classification. Non-limiting rejection labels may include ABMR, TCMR, mixed ABMR+TCMR, and no rejection. The probability rejection score of each rejection label may be generated based on a plurality of sets of weights and expression levels of genes.
    Type: Application
    Filed: April 28, 2023
    Publication date: November 2, 2023
    Inventors: Hao ZHANG, Francois COLLIN, Steven STONE, Kunbin QU
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20220259675
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: February 23, 2022
    Publication date: August 18, 2022
    Applicant: MYRIAD GENETICS, INC.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia E. Reid
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20220112565
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Application
    Filed: September 24, 2021
    Publication date: April 14, 2022
    Applicant: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Julia Reid
  • Gene signatures for cancer prognosis
    Patent number: 11174517
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: November 16, 2021
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Julia Reid
  • Gene signatures for cancer prognosis
    Patent number: 10954568
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: March 23, 2021
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia E. Reid
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20210071269
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Application
    Filed: November 12, 2020
    Publication date: March 11, 2021
    Applicant: MYRIAD GENETICS, INC.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Gene signatures for cancer prognosis
    Patent number: 10876164
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: December 29, 2020
    Assignee: MYRIAD GENETICS, INC.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • CANCER BIOMARKERS
    Publication number: 20200056246
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: October 25, 2019
    Publication date: February 20, 2020
    Applicant: MYRIAD GENETICS, INC.
    Inventors: Steven STONE, Alexander GUTIN, Susanne WAGNER, Julia REID
  • Cancer Biomarkers
    Patent number: 10519513
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: December 31, 2019
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Cancer biomarkers
    Patent number: 10501807
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: December 10, 2019
    Assignee: MYRIAD GENETICS, INC.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • CANCER BIOMARKERS
    Publication number: 20190153542
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: January 24, 2019
    Publication date: May 23, 2019
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20180334722
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: March 14, 2018
    Publication date: November 22, 2018
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia E. Reid
  • CANCER BIOMARKERS
    Publication number: 20180265930
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: March 13, 2018
    Publication date: September 20, 2018
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Cancer biomarkers
    Patent number: 9976188
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: May 22, 2018
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • CANCER BIOMARKERS
    Publication number: 20170247768
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 31, 2017
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20170152571
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Application
    Filed: November 11, 2016
    Publication date: June 1, 2017
    Inventors: Steven Stone, Alexander Gutin, Julia Reid
  • GENE SIGNATURES FOR CANCER DIAGNOSIS AND PROGNOSIS
    Publication number: 20170096712
    Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.
    Type: Application
    Filed: August 15, 2016
    Publication date: April 6, 2017
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Gene signatures for cancer diagnosis and prognosis
    Patent number: 9605319
    Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: March 28, 2017
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid